RNASEL and prostate cancer: Previously, Li et al.[16] performed a meta-analysis of the association of these two variants in RNASEL and prostate cancer risk, which included 11 case-control studies (each study contains the frequency of genotypes), and suggested that the Asp541Glu polymorphism was associated with an increased risk of prostate cancer in Caucasians.